BILLERICA, Mass., Jan. 2, 2019 /PRNewswire/ -- Bruker
Corporation (NASDAQ: BRKR) announced today it will participate in
the 37th annual J.P. Morgan Healthcare Conference in
San Francisco. Frank Laukien, Chairman, President & CEO and
Gerald Herman, CFO will present on
behalf of the company on Monday, January
7th, 2019 at 9:00 AM
Pacific Time.
A live audio webcast of the presentation will be available on
the Investor Relations section of the Company's website at
https://ir.bruker.com . A replay of the presentation will be posted
in the "Events & Presentations" section of the Bruker
Corporation Investor Relations website after the event and will be
available for 30 days following the presentation.
About Bruker Corporation (NASDAQ: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker's high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
Contact:
Miroslava
Minkova
Director, Investor Relations & Corporate Development
Bruker
Corporation
T: +1 (978) 663 – 3660, ext.
1479
E:
Miroslava.Minkova@Bruker.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bruker-corporation-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300771564.html
SOURCE Bruker Corporation